Daikaffil Chemicals India Limited has confirmed the book closure period for its 34th Annual General Meeting. The register of members and share transfer books will remain closed from September 16, 2026, to September 22, 2026.

The company issued the intimation pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This ensures that shareholders on record during this window are eligible to vote at the upcoming meeting.

Meeting Details

The 34th AGM is scheduled for Tuesday, September 22, 2026, at 4:00 pm. The meeting will be conducted via Video Conferencing or Other Audio-Visual Means. Physical attendance is not permitted for this event.

Business Items

The primary agenda includes the adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. Shareholders will also vote on the reappointment of Sadashiv K Shetty as a Non-Executive, Non-Independent Director and Chairman.

Director Reappointment

Sadashiv K Shetty retires by rotation and is eligible for reappointment. He serves as the brother of Managing Director Raghuram K Shetty. Shetty holds a Master's degree in chemistry and has over three decades of experience in the agrochemicals industry.

He attended all six board meetings during FY25-26. His remuneration for the period was nil. He currently holds directorships in Heranba Industries Ltd, Chemino Pharma Limited, Mikusu India Pvt Ltd, Heranba Organics Pvt Ltd, and Heranba Crop Care Limited.

Daikaffil Chemicals India Limited reported a consolidated net profit of ₹42.47 lakh for the quarter ended June 30, 2026, marking a turnaround from the ₹42.47 lakh loss incurred in the same period of the previous fiscal year. The company’s standalone segment, however, continued to face operational headwinds, registering a net loss of ₹63.73 lakh against total income from operations of ₹63.63 lakh.

The board of directors approved the unaudited financial results in a meeting held on August 14, 2026. The results were subsequently published in The Free Press Journal and Navshakti on August 15, 2026, and filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Consolidated total income from operations for the quarter stood at ₹340.05 lakh, compared to ₹1,304.06 lakh for the full year ended March 31, 2026. The consolidated earnings per share (EPS) was ₹0.71, contrasting with the diluted EPS of (₹3.57) for the full previous fiscal year.

In the standalone segment, the company reported a pre-tax loss of ₹63.63 lakh. The comprehensive income for the standalone entity was (₹62.05 lakh). For the consolidated entity, total comprehensive income was ₹40.68 lakh.

What the Numbers Show

The divergence between the standalone and consolidated results highlights the contribution of subsidiaries to the group’s profitability in the current quarter. While the parent company operated at a loss, with expenses exceeding its operational income of ₹63.63 lakh, the consolidated group achieved a positive net profit of ₹42.47 lakh. This suggests that subsidiary entities generated sufficient surplus to offset the standalone deficit, driving the overall group result into positive territory compared to the prior year's loss.

The company’s equity share capital remained unchanged at ₹600.00 lakh. The full format of the financial results is available on the BSE website and the company’s official portal.